Electrical devices for functional visceral pain

Camilleri, Michael

doi:10.1111/nmo.14518

Cited by 2 publications

(3 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Electrical stimulation through means such as electroacupuncture, transcutaneous electrical acustimulation (TEA), auricular electrical stimulation (AES) or sacral nerve modulation (SNM) has gained increasing attention over the years. 200 AES was shown by Kovacic et al to be effective in improving chronic functional abdominal pain in paediatric patients via a double-blind, sham-controlled RCT. 201 Similar outcomes were found in adult patients with constipationpredominant IBS using AES.…”

Section: Non-pharmacological Therapies-future Technologiesmentioning

confidence: 99%

Review article: Functional dyspepsia and pregnancy—Effects and management in a special population

Liu

Starkey

Virani

et al. 2023

Aliment Pharmacol Ther

View full text Add to dashboard Cite

Background: Around 10% of Americans meet the Rome IV criteria for functional dyspepsia (FD), with a significantly higher rate in women. FD also has a higher prevalence in women below the age of 50, suggesting that women who are affected are likely to be of reproductive age. Unfortunately, there is a lack of research or evidence-based guidelines on managing FD in pregnancy. Aims and Methods:To address this issue, we aimed to perform a systematic review of the interactions between FD and pregnancy and managing pre-existing FD in the peripartum and post-partum phases using current lifestyle, pharmacological, nonpharmacological and alternative medicine interventions. Results: Due to the lack of Rome IV FD-specific data in pregnancy, we instead performed a narrative review on how existing FD interventions could be extrapolated to the pregnant population. Where possible we use the highest level of available evidence or official guidelines to answer these questions, which often involves synthesising treatment and safety evidence of these interventions in other diseases during pregnancy. Finally, we highlight current substantial knowledge gaps requiring further research for the safe management of a pregnant patient with pre-existing FD. Conclusions: Overall, despite the paucity of knowledge of treating FD during pregnancy, providers can mitigate this uncertainty by planning ahead with the patient. Patients should ideally minimise treatment until after breastfeeding. However, interdisciplinary resources are available to ensure that minimal-risk interventions are maximised, while interventions with more risks, if necessary, are justifiable by both the patient and the care team. Future investigations should continue to elicit the mechanistic relationship between FD and pregnancy while cautiously expanding prospective research on promising and safe therapies in pregnant patients with preexisting FD.

show abstract

Section: Non-pharmacological Therapies-future Technologiesmentioning

confidence: 99%

Review article: Functional dyspepsia and pregnancy—Effects and management in a special population

Liu

Starkey

Virani

et al. 2023

Aliment Pharmacol Ther

View full text Add to dashboard Cite

show abstract

“…It has become increasingly popular because it is a noninvasive, needleless, and self‐administrative technique that is well tolerated by patients. It has been shown to be beneficial in treating GI motility disorders 3–5 …”

Section: Introductionmentioning

confidence: 99%

“…It has been shown to be beneficial in treating GI motility disorders. [3][4][5] This review paper will discuss the different TES techniques available, including transcutaneous peripheral nerve stimulation (TPNS), transcutaneous electrical acustimulation (TEA), transcutaneous interferential current (IFC), and transcutaneous electrical nerve stimulation (TENS). Additionally, this paper will review the available TES studies in GI motility disorders of the esophagus, stomach, small intestines, and colon.…”

mentioning

confidence: 99%

Transcutaneous electrical stimulation for gastrointestinal motility disorders

Song,

Trujillo,

et al. 2023

Neurogastroenterology Motil

View full text Add to dashboard Cite

Background/PurposeGastrointestinal (GI) dysmotility is categorized by muscle or nerve dysfunctions in any portion of the GI tract, which leads to abnormalities in GI motor and sensory function. Symptoms may vary depending on the organ affected and can be debilitating. Treatment usually involves diet and lifestyle changes. Pharmacotherapy is limited in effectiveness with various side effects. Transcutaneous electrical stimulation (TES), a noninvasive, needleless technique that provides electrical stimulation using cutaneous non‐needle electrodes, has become increasingly popular. It has been shown to be beneficial in treating GI motility disorders.MethodsThis review paper navigates through the different TES techniques, including transcutaneous peripheral nerve (vagal/sacral/tibial nerves) electrical stimulation, transcutaneous electrical acustimulation (stimulation via acupuncture point), transcutaneous interferential current therapy, and transcutaneous electrical nerve stimulation.Key ResultsAs we delve deeper, we explore the promising effects of TES on dysphagia, gastroesophageal reflux disease, functional dyspepsia, gastroparesis, postoperative ileus, constipation, and irritable bowel syndrome. The literature at hand speaks volumes about the therapeutic prowess of this noninvasive technique.Conclusion & InferencesThe time is ripe to evaluate further the full therapeutic potential of TES, a noninvasive, nonpharmaceutical, nonsurgical, and home‐based self‐administrative technique in managing GI motility disorders.

show abstract

Electrical devices for functional visceral pain

Cited by 2 publications

References 28 publications

Review article: Functional dyspepsia and pregnancy—Effects and management in a special population

Review article: Functional dyspepsia and pregnancy—Effects and management in a special population

Transcutaneous electrical stimulation for gastrointestinal motility disorders

Contact Info

Product

Resources

About